title: Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.
authors.affiliation: Department of Medicine, University of Maryland Hospital, University of Maryland Cancer Center, Baltimore 21201.
authors.forename: C P
authors.initials: CP
authors.lastname: Belani
authors.forename: M
authors.initials: M
authors.lastname: Eisenberger
authors.forename: D
authors.initials: D
authors.lastname: Van Echo
authors.forename: D
authors.initials: D
authors.lastname: Hiponia
authors.forename: J
authors.initials: J
authors.lastname: Aisner
mesh_terms: D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003953:Diagnosis-Related Groups; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local
chemical_list: C044466:caracemide; D006918:Hydroxyurea